Daniela Mazzocchi
Overview
Explore the profile of Daniela Mazzocchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laria A, Lurati A, Zizzo G, Zaccara E, Mazzocchi D, Re K, et al.
Front Med (Lausanne)
. 2022 Jun;
9:837133.
PMID: 35646974
Rheumatoid arthritis (RA) is a systemic inflammatory disease, which primarily causes symmetric polyarthritis. An extrarticolar involvement is common, and the commonly involved organ is lungs. Although cardiac disease is responsible...
2.
Lurati A, Laria A, Mazzocchi D, Re K, Marrazza M, Faggioli P, et al.
Open Access Rheumatol
. 2021 May;
13:73-78.
PMID: 33953620
Objective: The aim of our study was to evaluate the possible role of biological treatments for rheumatoid arthritis (RA) in improving the glycemic profile in patients affected not only by...
3.
Laria A, Lurati A, Marrazza M, Mazzocchi D, Re K, Scarpellini M
J Inflamm Res
. 2016 Mar;
9:1-11.
PMID: 26929657
Macrophages belong to the innate immune system giving us protection against pathogens. However it is known that they are also involved in rheumatic diseases. Activated macrophages have two different phenotypes...
4.
Laria A, Lurati A, Re K, Marrazza M, Mazzocchi D, Farina A, et al.
Patient Relat Outcome Meas
. 2015 Jun;
6:139-44.
PMID: 26056502
Purpose: Administration of intravenous iloprost - a first-line European League Against Rheumatism (EULAR)-recommended choice for the treatment of scleroderma (SSc)-related digital vasculopathy - requires repeated treatment cycles of 6 hours...